发明名称 Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
摘要 Provided are combinations and pharmaceutical compositions comprising bendamustine and a HDAC inhibitor. A preferred HDAC inhibitor is N-hydroxy-4-{ 2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy} -benzamide. The combinations and pharmaceutical compositions are useful in the treatment of cancer.
申请公布号 NZ621221(A) 申请公布日期 2016.07.29
申请号 NZ20110621221 申请日期 2011.09.13
申请人 PHARMACYCLICS LLC 发明人 BUGGY JOSEPH J.;MODY TARAK D.;VERNER ERIK J.;PURRO NORBERT;BALASUBRAMANIAN SRIRAM;KLOOS IOANA;DEPIL STÉPHANE;LOURY DAVID J.
分类号 A61K31/343;A61K9/14;A61K9/28;A61K31/4184;A61P35/00 主分类号 A61K31/343
代理机构 代理人
主权项
地址